1 Market Overview 1.1 Molecular Diagnosis and Therapy Product Introduction 1.2 Global Molecular Diagnosis and Therapy Market Size Forecast 1.3 Molecular Diagnosis and Therapy Market Trends & Drivers 1.3.1 Molecular Diagnosis and Therapy Industry Trends 1.3.2 Molecular Diagnosis and Therapy Market Drivers & Opportunity 1.3.3 Molecular Diagnosis and Therapy Market Challenges 1.3.4 Molecular Diagnosis and Therapy Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Molecular Diagnosis and Therapy Players Revenue Ranking (2023) 2.2 Global Molecular Diagnosis and Therapy Revenue by Company (2019-2024) 2.3 Key Companies Molecular Diagnosis and Therapy Manufacturing Base Distribution and Headquarters 2.4 Key Companies Molecular Diagnosis and Therapy Product Offered 2.5 Key Companies Time to Begin Mass Production of Molecular Diagnosis and Therapy 2.6 Molecular Diagnosis and Therapy Market Competitive Analysis 2.6.1 Molecular Diagnosis and Therapy Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Molecular Diagnosis and Therapy Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis and Therapy as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 PCR 3.1.2 DNA Sequencing 3.1.3 NGS 3.2 Global Molecular Diagnosis and Therapy Sales Value by Type 3.2.1 Global Molecular Diagnosis and Therapy Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Molecular Diagnosis and Therapy Sales Value, by Type (2019-2030) 3.2.3 Global Molecular Diagnosis and Therapy Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Diagnostic Laboratories 4.1.2 Research & Academic Laboratories 4.2 Global Molecular Diagnosis and Therapy Sales Value by Application 4.2.1 Global Molecular Diagnosis and Therapy Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Molecular Diagnosis and Therapy Sales Value, by Application (2019-2030) 4.2.3 Global Molecular Diagnosis and Therapy Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Molecular Diagnosis and Therapy Sales Value by Region 5.1.1 Global Molecular Diagnosis and Therapy Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Molecular Diagnosis and Therapy Sales Value by Region (2019-2024) 5.1.3 Global Molecular Diagnosis and Therapy Sales Value by Region (2025-2030) 5.1.4 Global Molecular Diagnosis and Therapy Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Molecular Diagnosis and Therapy Sales Value, 2019-2030 5.2.2 North America Molecular Diagnosis and Therapy Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Molecular Diagnosis and Therapy Sales Value, 2019-2030 5.3.2 Europe Molecular Diagnosis and Therapy Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Molecular Diagnosis and Therapy Sales Value, 2019-2030 5.4.2 Asia Pacific Molecular Diagnosis and Therapy Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Molecular Diagnosis and Therapy Sales Value, 2019-2030 5.5.2 South America Molecular Diagnosis and Therapy Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Molecular Diagnosis and Therapy Sales Value, 2019-2030 5.6.2 Middle East & Africa Molecular Diagnosis and Therapy Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Molecular Diagnosis and Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Molecular Diagnosis and Therapy Sales Value 6.3 United States 6.3.1 United States Molecular Diagnosis and Therapy Sales Value, 2019-2030 6.3.2 United States Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Molecular Diagnosis and Therapy Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Molecular Diagnosis and Therapy Sales Value, 2019-2030 6.4.2 Europe Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Molecular Diagnosis and Therapy Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Molecular Diagnosis and Therapy Sales Value, 2019-2030 6.5.2 China Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 6.5.3 China Molecular Diagnosis and Therapy Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Molecular Diagnosis and Therapy Sales Value, 2019-2030 6.6.2 Japan Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Molecular Diagnosis and Therapy Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Molecular Diagnosis and Therapy Sales Value, 2019-2030 6.7.2 South Korea Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Molecular Diagnosis and Therapy Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Molecular Diagnosis and Therapy Sales Value, 2019-2030 6.8.2 Southeast Asia Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Molecular Diagnosis and Therapy Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Molecular Diagnosis and Therapy Sales Value, 2019-2030 6.9.2 India Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 6.9.3 India Molecular Diagnosis and Therapy Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Abbott Laboratories 7.1.1 Abbott Laboratories Profile 7.1.2 Abbott Laboratories Main Business 7.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Products, Services and Solutions 7.1.4 Abbott Laboratories Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.1.5 Abbott Laboratories Recent Developments 7.2 Agilent Technologies 7.2.1 Agilent Technologies Profile 7.2.2 Agilent Technologies Main Business 7.2.3 Agilent Technologies Molecular Diagnosis and Therapy Products, Services and Solutions 7.2.4 Agilent Technologies Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.2.5 Agilent Technologies Recent Developments 7.3 Becton, Dickinson and Company 7.3.1 Becton, Dickinson and Company Profile 7.3.2 Becton, Dickinson and Company Main Business 7.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Products, Services and Solutions 7.3.4 Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.3.5 Biomérieux Sa Recent Developments 7.4 Biomérieux Sa 7.4.1 Biomérieux Sa Profile 7.4.2 Biomérieux Sa Main Business 7.4.3 Biomérieux Sa Molecular Diagnosis and Therapy Products, Services and Solutions 7.4.4 Biomérieux Sa Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.4.5 Biomérieux Sa Recent Developments 7.5 Danaher Corporation 7.5.1 Danaher Corporation Profile 7.5.2 Danaher Corporation Main Business 7.5.3 Danaher Corporation Molecular Diagnosis and Therapy Products, Services and Solutions 7.5.4 Danaher Corporation Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.5.5 Danaher Corporation Recent Developments 7.6 Diasorin 7.6.1 Diasorin Profile 7.6.2 Diasorin Main Business 7.6.3 Diasorin Molecular Diagnosis and Therapy Products, Services and Solutions 7.6.4 Diasorin Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.6.5 Diasorin Recent Developments 7.7 Grifols 7.7.1 Grifols Profile 7.7.2 Grifols Main Business 7.7.3 Grifols Molecular Diagnosis and Therapy Products, Services and Solutions 7.7.4 Grifols Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.7.5 Grifols Recent Developments 7.8 Hologic 7.8.1 Hologic Profile 7.8.2 Hologic Main Business 7.8.3 Hologic Molecular Diagnosis and Therapy Products, Services and Solutions 7.8.4 Hologic Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.8.5 Hologic Recent Developments 7.9 Illumina 7.9.1 Illumina Profile 7.9.2 Illumina Main Business 7.9.3 Illumina Molecular Diagnosis and Therapy Products, Services and Solutions 7.9.4 Illumina Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.9.5 Illumina Recent Developments 7.10 Qiagen 7.10.1 Qiagen Profile 7.10.2 Qiagen Main Business 7.10.3 Qiagen Molecular Diagnosis and Therapy Products, Services and Solutions 7.10.4 Qiagen Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.10.5 Qiagen Recent Developments 7.11 Roche Diagnostics 7.11.1 Roche Diagnostics Profile 7.11.2 Roche Diagnostics Main Business 7.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Products, Services and Solutions 7.11.4 Roche Diagnostics Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.11.5 Roche Diagnostics Recent Developments 7.12 Siemens AG 7.12.1 Siemens AG Profile 7.12.2 Siemens AG Main Business 7.12.3 Siemens AG Molecular Diagnosis and Therapy Products, Services and Solutions 7.12.4 Siemens AG Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.12.5 Siemens AG Recent Developments 7.13 Thermo Fisher Scientific 7.13.1 Thermo Fisher Scientific Profile 7.13.2 Thermo Fisher Scientific Main Business 7.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Products, Services and Solutions 7.13.4 Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue (US$ Million) & (2019-2024) 7.13.5 Thermo Fisher Scientific Recent Developments 8 Industry Chain Analysis 8.1 Molecular Diagnosis and Therapy Industrial Chain 8.2 Molecular Diagnosis and Therapy Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Molecular Diagnosis and Therapy Sales Model 8.5.2 Sales Channel 8.5.3 Molecular Diagnosis and Therapy Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Molecular Diagnosis and Therapy Market Trends Table 2. Molecular Diagnosis and Therapy Market Drivers & Opportunity Table 3. Molecular Diagnosis and Therapy Market Challenges Table 4. Molecular Diagnosis and Therapy Market Restraints Table 5. Global Molecular Diagnosis and Therapy Revenue by Company (2019-2024) & (US$ Million) Table 6. Global Molecular Diagnosis and Therapy Revenue Market Share by Company (2019-2024) Table 7. Key Companies Molecular Diagnosis and Therapy Manufacturing Base Distribution and Headquarters Table 8. Key Companies Molecular Diagnosis and Therapy Product Type Table 9. Key Companies Time to Begin Mass Production of Molecular Diagnosis and Therapy Table 10. Global Molecular Diagnosis and Therapy Companies Market Concentration Ratio (CR5 and HHI) Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis and Therapy as of 2023) Table 12. Mergers & Acquisitions, Expansion Plans Table 13. Global Molecular Diagnosis and Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 14. Global Molecular Diagnosis and Therapy Sales Value by Type (2019-2024) & (US$ Million) Table 15. Global Molecular Diagnosis and Therapy Sales Value by Type (2025-2030) & (US$ Million) Table 16. Global Molecular Diagnosis and Therapy Sales Market Share in Value by Type (2019-2024) & (%) Table 17. Global Molecular Diagnosis and Therapy Sales Market Share in Value by Type (2025-2030) & (%) Table 18. Global Molecular Diagnosis and Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 19. Global Molecular Diagnosis and Therapy Sales Value by Application (2019-2024) & (US$ Million) Table 20. Global Molecular Diagnosis and Therapy Sales Value by Application (2025-2030) & (US$ Million) Table 21. Global Molecular Diagnosis and Therapy Sales Market Share in Value by Application (2019-2024) & (%) Table 22. Global Molecular Diagnosis and Therapy Sales Market Share in Value by Application (2025-2030) & (%) Table 23. Global Molecular Diagnosis and Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 24. Global Molecular Diagnosis and Therapy Sales Value by Region (2019-2024) & (US$ Million) Table 25. Global Molecular Diagnosis and Therapy Sales Value by Region (2025-2030) & (US$ Million) Table 26. Global Molecular Diagnosis and Therapy Sales Value by Region (2019-2024) & (%) Table 27. Global Molecular Diagnosis and Therapy Sales Value by Region (2025-2030) & (%) Table 28. Key Countries/Regions Molecular Diagnosis and Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030 Table 29. Key Countries/Regions Molecular Diagnosis and Therapy Sales Value, (2019-2024) & (US$ Million) Table 30. Key Countries/Regions Molecular Diagnosis and Therapy Sales Value, (2025-2030) & (US$ Million) Table 31. Abbott Laboratories Basic Information List Table 32. Abbott Laboratories Description and Business Overview Table 33. Abbott Laboratories Molecular Diagnosis and Therapy Products, Services and Solutions Table 34. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Abbott Laboratories (2019-2024) Table 35. Abbott Laboratories Recent Developments Table 36. Agilent Technologies Basic Information List Table 37. Agilent Technologies Description and Business Overview Table 38. Agilent Technologies Molecular Diagnosis and Therapy Products, Services and Solutions Table 39. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Agilent Technologies (2019-2024) Table 40. Agilent Technologies Recent Developments Table 41. Becton, Dickinson and Company Basic Information List Table 42. Becton, Dickinson and Company Description and Business Overview Table 43. Becton, Dickinson and Company Molecular Diagnosis and Therapy Products, Services and Solutions Table 44. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Becton, Dickinson and Company (2019-2024) Table 45. Becton, Dickinson and Company Recent Developments Table 46. Biomérieux Sa Basic Information List Table 47. Biomérieux Sa Description and Business Overview Table 48. Biomérieux Sa Molecular Diagnosis and Therapy Products, Services and Solutions Table 49. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Biomérieux Sa (2019-2024) Table 50. Biomérieux Sa Recent Developments Table 51. Danaher Corporation Basic Information List Table 52. Danaher Corporation Description and Business Overview Table 53. Danaher Corporation Molecular Diagnosis and Therapy Products, Services and Solutions Table 54. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Danaher Corporation (2019-2024) Table 55. Danaher Corporation Recent Developments Table 56. Diasorin Basic Information List Table 57. Diasorin Description and Business Overview Table 58. Diasorin Molecular Diagnosis and Therapy Products, Services and Solutions Table 59. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Diasorin (2019-2024) Table 60. Diasorin Recent Developments Table 61. Grifols Basic Information List Table 62. Grifols Description and Business Overview Table 63. Grifols Molecular Diagnosis and Therapy Products, Services and Solutions Table 64. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Grifols (2019-2024) Table 65. Grifols Recent Developments Table 66. Hologic Basic Information List Table 67. Hologic Description and Business Overview Table 68. Hologic Molecular Diagnosis and Therapy Products, Services and Solutions Table 69. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Hologic (2019-2024) Table 70. Hologic Recent Developments Table 71. Illumina Basic Information List Table 72. Illumina Description and Business Overview Table 73. Illumina Molecular Diagnosis and Therapy Products, Services and Solutions Table 74. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Illumina (2019-2024) Table 75. Illumina Recent Developments Table 76. Qiagen Basic Information List Table 77. Qiagen Description and Business Overview Table 78. Qiagen Molecular Diagnosis and Therapy Products, Services and Solutions Table 79. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Qiagen (2019-2024) Table 80. Qiagen Recent Developments Table 81. Roche Diagnostics Basic Information List Table 82. Roche Diagnostics Description and Business Overview Table 83. Roche Diagnostics Molecular Diagnosis and Therapy Products, Services and Solutions Table 84. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Roche Diagnostics (2019-2024) Table 85. Roche Diagnostics Recent Developments Table 86. Siemens AG Basic Information List Table 87. Siemens AG Description and Business Overview Table 88. Siemens AG Molecular Diagnosis and Therapy Products, Services and Solutions Table 89. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Siemens AG (2019-2024) Table 90. Siemens AG Recent Developments Table 91. Thermo Fisher Scientific Basic Information List Table 92. Thermo Fisher Scientific Description and Business Overview Table 93. Thermo Fisher Scientific Molecular Diagnosis and Therapy Products, Services and Solutions Table 94. Revenue (US$ Million) in Molecular Diagnosis and Therapy Business of Thermo Fisher Scientific (2019-2024) Table 95. Thermo Fisher Scientific Recent Developments Table 96. Key Raw Materials Lists Table 97. Raw Materials Key Suppliers Lists Table 98. Molecular Diagnosis and Therapy Downstream Customers Table 99. Molecular Diagnosis and Therapy Distributors List Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources Table 103. Business Unit and Senior & Team Lead Analysts List of Figures Figure 1. Molecular Diagnosis and Therapy Product Picture Figure 2. Global Molecular Diagnosis and Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Molecular Diagnosis and Therapy Sales Value (2019-2030) & (US$ Million) Figure 4. Molecular Diagnosis and Therapy Report Years Considered Figure 5. Global Molecular Diagnosis and Therapy Players Revenue Ranking (2023) & (US$ Million) Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Molecular Diagnosis and Therapy Revenue in 2023 Figure 7. Molecular Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 8. PCR Picture Figure 9. DNA Sequencing Picture Figure 10. NGS Picture Figure 11. Global Molecular Diagnosis and Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million) Figure 12. Global Molecular Diagnosis and Therapy Sales Value Market Share by Type, 2023 & 2030 Figure 13. Product Picture of Diagnostic Laboratories Figure 14. Product Picture of Research & Academic Laboratories Figure 15. Global Molecular Diagnosis and Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million) Figure 16. Global Molecular Diagnosis and Therapy Sales Value Market Share by Application, 2023 & 2030 Figure 17. North America Molecular Diagnosis and Therapy Sales Value (2019-2030) & (US$ Million) Figure 18. North America Molecular Diagnosis and Therapy Sales Value by Country (%), 2023 VS 2030 Figure 19. Europe Molecular Diagnosis and Therapy Sales Value (2019-2030) & (US$ Million) Figure 20. Europe Molecular Diagnosis and Therapy Sales Value by Country (%), 2023 VS 2030 Figure 21. Asia Pacific Molecular Diagnosis and Therapy Sales Value (2019-2030) & (US$ Million) Figure 22. Asia Pacific Molecular Diagnosis and Therapy Sales Value by Country (%), 2023 VS 2030 Figure 23. South America Molecular Diagnosis and Therapy Sales Value (2019-2030) & (US$ Million) Figure 24. South America Molecular Diagnosis and Therapy Sales Value by Country (%), 2023 VS 2030 Figure 25. Middle East & Africa Molecular Diagnosis and Therapy Sales Value (2019-2030) & (US$ Million) Figure 26. Middle East & Africa Molecular Diagnosis and Therapy Sales Value by Country (%), 2023 VS 2030 Figure 27. Key Countries/Regions Molecular Diagnosis and Therapy Sales Value (%), (2019-2030) Figure 28. United States Molecular Diagnosis and Therapy Sales Value, (2019-2030) & (US$ Million) Figure 29. United States Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 Figure 30. United States Molecular Diagnosis and Therapy Sales Value by Application (%), 2023 VS 2030 Figure 31. Europe Molecular Diagnosis and Therapy Sales Value, (2019-2030) & (US$ Million) Figure 32. Europe Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 Figure 33. Europe Molecular Diagnosis and Therapy Sales Value by Application (%), 2023 VS 2030 Figure 34. China Molecular Diagnosis and Therapy Sales Value, (2019-2030) & (US$ Million) Figure 35. China Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 Figure 36. China Molecular Diagnosis and Therapy Sales Value by Application (%), 2023 VS 2030 Figure 37. Japan Molecular Diagnosis and Therapy Sales Value, (2019-2030) & (US$ Million) Figure 38. Japan Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 Figure 39. Japan Molecular Diagnosis and Therapy Sales Value by Application (%), 2023 VS 2030 Figure 40. South Korea Molecular Diagnosis and Therapy Sales Value, (2019-2030) & (US$ Million) Figure 41. South Korea Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 Figure 42. South Korea Molecular Diagnosis and Therapy Sales Value by Application (%), 2023 VS 2030 Figure 43. Southeast Asia Molecular Diagnosis and Therapy Sales Value, (2019-2030) & (US$ Million) Figure 44. Southeast Asia Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 Figure 45. Southeast Asia Molecular Diagnosis and Therapy Sales Value by Application (%), 2023 VS 2030 Figure 46. India Molecular Diagnosis and Therapy Sales Value, (2019-2030) & (US$ Million) Figure 47. India Molecular Diagnosis and Therapy Sales Value by Type (%), 2023 VS 2030 Figure 48. India Molecular Diagnosis and Therapy Sales Value by Application (%), 2023 VS 2030 Figure 49. Molecular Diagnosis and Therapy Industrial Chain Figure 50. Molecular Diagnosis and Therapy Manufacturing Cost Structure Figure 51. Channels of Distribution (Direct Sales, and Distribution) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation